These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

373 related items for PubMed ID: 17626074

  • 1. Unique signaling properties of CTAR1 in LMP1-mediated transformation.
    Mainou BA, Everly DN, Raab-Traub N.
    J Virol; 2007 Sep; 81(18):9680-92. PubMed ID: 17626074
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG, Blake SM, Floettmann JE, Rowe M, Young LS.
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
    Mainou BA, Everly DN, Raab-Traub N.
    Oncogene; 2005 Oct 20; 24(46):6917-24. PubMed ID: 16007144
    [Abstract] [Full Text] [Related]

  • 4. Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1.
    Xie P, Bishop GA.
    J Immunol; 2004 Nov 01; 173(9):5546-55. PubMed ID: 15494504
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.
    Kung CP, Raab-Traub N.
    J Virol; 2010 Jul 01; 84(13):6605-14. PubMed ID: 20410275
    [Abstract] [Full Text] [Related]

  • 6. TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1.
    Schultheiss U, Püschner S, Kremmer E, Mak TW, Engelmann H, Hammerschmidt W, Kieser A.
    EMBO J; 2001 Oct 15; 20(20):5678-91. PubMed ID: 11598011
    [Abstract] [Full Text] [Related]

  • 7. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E, Mougel A, Goormachtigh G, Loing E, Fafeur V, Auriault C, Coll J.
    Oncogene; 2004 Apr 08; 23(15):2681-93. PubMed ID: 14767477
    [Abstract] [Full Text] [Related]

  • 8. LMP1 strain variants: biological and molecular properties.
    Mainou BA, Raab-Traub N.
    J Virol; 2006 Jul 08; 80(13):6458-68. PubMed ID: 16775333
    [Abstract] [Full Text] [Related]

  • 9. BS69 cooperates with TRAF3 in the regulation of Epstein-Barr virus-derived LMP1/CTAR1-induced NF-kappaB activation.
    Ikeda O, Miyasaka Y, Yoshida R, Mizushima A, Oritani K, Sekine Y, Kuroda M, Yasui T, Fujimuro M, Muromoto R, Nanbo A, Matsuda T.
    FEBS Lett; 2010 Mar 05; 584(5):865-72. PubMed ID: 20138174
    [Abstract] [Full Text] [Related]

  • 10. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
    Eliopoulos AG, Young LS.
    Oncogene; 1998 Apr 02; 16(13):1731-42. PubMed ID: 9582021
    [Abstract] [Full Text] [Related]

  • 11. LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.
    Thornburg NJ, Kulwichit W, Edwards RH, Shair KH, Bendt KM, Raab-Traub N.
    Oncogene; 2006 Jan 12; 25(2):288-97. PubMed ID: 16247482
    [Abstract] [Full Text] [Related]

  • 12. The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.
    Wu L, Nakano H, Wu Z.
    J Biol Chem; 2006 Jan 27; 281(4):2162-9. PubMed ID: 16280329
    [Abstract] [Full Text] [Related]

  • 13. Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms.
    Busch LK, Bishop GA.
    J Immunol; 2001 Nov 15; 167(10):5805-13. PubMed ID: 11698454
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.